FOR IMMEDIATE RELEASE
UK Biomedical Company harnesses the power of ‘The Body Electric’
NuroKor® to deliver pain relieving bioelectronics into the teeth of the U.S. opioid storm.
Ypsilanti, MI, October 15, 2018 – London-based Nurokor, Ltd. has signed an exclusive distribution agreement with NuroKor-USA to market bioelectrical medical devices and systems that will give Americans a proven alternative to pharmaceuticals for managing pain.
According to Dr Julian Grove, president of the Arizona Pain Society and an advisor who worked with Arizona State on prescribing rules, "A lot of practitioners are reducing opioid medications, not from a clinical perspective, but more from a legal and regulatory perspective for fear of investigation," Grove has said. "No practitioner wants to be the highest prescriber”
NuroKor-USA president John Nycz is a passionate voice for change and knows first-hand the potential of bioelectrical medicine.
After injury complications from a head-on collision in 1995, broken bones failed to heal and he was facing orthopedic surgery that would leave him with mobility-limiting joint fusion. Nycz researched his alternatives and found studies that indicated bioelectronic therapies stimulated bone growth. He sought out a physician who was also an acupuncturist. After 4 weeks of treatment hard bone growth was underway and the bone healed completely.
Stylist and environmental artist Robert Ruffer is another compelling advocate for effective bioelectrical alternatives to opioids. After severing his left arm with a table saw, it was reattached at the University of Michigan Medical Center. He was taking an opioid cocktail of OxyContin and Vicodin for excruciating pain before discovering Peripheral Nerve Stimulation (PNS).
“By using PNS I was able to manage the pain down to the point I could sleep without taking any pain killers”.
The opioids had caused Ruffer other side effects, including upsetting his balance.
“Not taking pain killers is really important to me, I don’t just feel better mentally and physically, I’m no longer unstable when I walk. The last thing I need at this point in my recovery is to trip and fall.”
Not only did his physician approve the use of PNS for pain relief, he instructed Ruffer to ‘fire’ up his forearm muscles using Neuromuscular Electrical Stimulation, mitigating any scar tissue developing from the reattached tendons and ligaments.
Nurokor Bioelectrical medicine is in the vanguard of the movement for alternative pain treatment at a time of dramatic shift in attitudes to opioids. Nowhere is this shift more evident than at the US Department of Veterans Affairs, ( VA), which has sharply reduced the use of opioids to treat chronic pain in favor of once-unlikely alternatives.
Pain is rampant among veterans. Nearly 60 percent of Iraq and Afghanistan veterans are affected by chronic pain, as are more than 50 percent of older veterans. From 2001 to 2013, the VA dispensed opioids as the default pain remedy and prescriptions went up 270 percent while the number of patients rose less than 40 percent.
That’s no longer the case as they seek out and make available healthier options.
To meet this need, NuroKor will work with Alliant Healthcare’s MediSurge division to sell into the Federal Space. Alliant’s CEO and Air Force vet Bob Taylor added, “A big part of our mission is helping vets. With over 100 million Americans suffering from chronic pain, the math suggests that more than 2 million of the 5.6 million vets under care have pain issues. We can help a lot of people.”
These devices are FDA cleared for OTC (Over-The-Counter) sales, but can also be prescribed, which means they may be reimbursable.
NuroKor-USA is the authorized U.S. importer and distributor for NuroKor’s line of bioelectronic devices and accessories. The company’s mission is to evangelize and propagate the use of non-pharma bioelectronic technology advances for managing pain and enabling more effective rehab after surgery or injury!
John Nycz, President, NuroKor-USA